Eagle Veterinary Technology Co.,Ltd (KOSDAQ:044960)
South Korea
· Delayed Price · Currency is KRW 3,815.00
-135.00 (-3.42%)
At close: Mar 9, 2026
KOSDAQ:044960 Revenue
Eagle Veterinary Technology Co.,Ltd had revenue of 10.47B KRW in the quarter ending September 30, 2025, with 5.89% growth. This brings the company's revenue in the last twelve months to 42.51B, up 2.26% year-over-year. In the year 2024, Eagle Veterinary Technology Co.,Ltd had annual revenue of 41.72B, down -2.52%.
Revenue (ttm)
42.51B
Revenue Growth
+2.26%
P/S Ratio
1.13
Revenue / Employee
654.00M
Employees
65
Market Cap
48.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.72B | -1.08B | -2.52% |
| Dec 31, 2023 | 42.79B | -746.00M | -1.71% |
| Dec 31, 2022 | 43.54B | 3.10B | 7.67% |
| Dec 31, 2021 | 40.44B | 80.27M | 0.20% |
| Dec 31, 2020 | 40.36B | 5.93B | 17.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kyung Nam Pharm | 56.18B |
| Korea Arlico Pharm | 205.21B |
| GeneBioTech Co. ,Ltd | 92.28B |
| Korean Drug | 62.21B |
| RP Bio | 134.21B |
| Jin Yang Pharmaceutical | 117.19B |
| HLscience | 18.10B |
| Cosmax Nbt | 293.75B |